Table 2

 Characteristics of study population

Values are mean (SD, range) or absolute numbers.
CT data are given for observer 1.
COPD, chronic obstructive pulmonary disease; AAT, α1-antitrypsin deficiency; IPF, idiopathic pulmonary fibrosis; LAM, lymphangioleiomyomatosis; PPH, pulmonary arterial hypertension; CT, computed tomography; AT, air trapping; BO, bronchiolitis obliterans; FEV1, forced expiratory volume in 1 second.
Type of transplantation
    Single lung (n)21
    Double lung (n)16
    Heart lung (n)1
    Cystic fibrosis (n)13
    Emphysema/COPD (n)11
    AAT, IPF and LAM (n)3 each
    PAH, idiopathic obliterative bronchiolitis (n)2 each
    Langerhans cell histiocytosis, sarcoidosis (n)1 each
    FEV1 at baseline CT (% baseline post-transplant)82 (18, 34–100)
    FEV1 at follow up CT (% baseline post-transplant)77 (21, 27–100)
CT scores
    CTAT score at baseline CT (unit)47 (23, 0–100)
    CTAT score at follow up CT (unit)51 (23, 0–100)
    CTBO score at baseline CT (unit)7 (4, 1–16)
    CTBO score at follow up CT (unit)7 (5, 0–24)